Creation of arteriovenous fistulae for hemodialysis in octogenarians

• Published in: Hemodialysis international 2014-01, Vol.18 (1), p.113-117
• Main Authors: Watorek, Ewa, Golebiowski, Tomasz, Kusztal, Mariusz, Letachowicz, Krzysztof, Letachowicz, Waldemar, Augustyniak Bartosik, Hanna, Garcarek, Jerzy, Madziarska, Katarzyna, Weyde, Wacław, Klinger, Marian
• Format: Article
• Language: English
• Subjects: Aged, 80 and over; Arteriovenous fistula; Arteriovenous Shunt, Surgical - adverse effects; chronic hemodialysis; Female; Humans; Kidney Failure, Chronic - mortality; Kidney Failure, Chronic - therapy; Male; octogenarians; Renal Dialysis - adverse effects; Retrospective Studies; vascular access; Vascular Access Devices - adverse effects
• ISSN: 1492-7535; 1542-4758
• DOI: 10.1111/hdi.12076

Elderly patients, defined as octogenarians and nonagenarians, are an increasing population entering renal replacement therapy. Advanced age appears as an exclusive factor negatively influencing dialysis practice. Elderly patients are referred late for the initiation of hemodialysis and more likely are offered catheters rather than arteriovenous fistulae (AVF), which increase mortality and negatively affect quality of life. We present our approach to the creation of vascular access for hemodialysis in this demanding population. In 2006–2012, 39 patients aged 85.9 ± 2.05 with end‐stage renal disease, mainly resulting from ischemic nephropathy, were admitted to the Department of Nephrology to establish permanent vascular access for hemodialysis: preferably AVF. Temporary dialysis catheters were implanted in uremic emergency to bridge the time to fistula creation/maturation. AVF was attempted in 87.2% of the patients. Primary AVF function was achieved in 54% of the patients. Cumulative proportional survival of AVF at months 12 and 24 was 81.5%. Ninety‐four percent of AVF were localized on the forearm: 74% in the distal and 20% in the proximal part. Mean duration of hemodialysis therapy was 20.80 ± 19.45 months. The mean time of AVF use was 15.9 ± 20.2 months. Until present, 38% have been dialyzed using AVF for 31.0 ± 18.8 months. Five patients died with functioning fistula. Eight patients initiated hemodialysis therapy with fistula. During further observation, the use of AVF increased to 62%. Elderly patients should not be denied creation of AVF as a rule. The outcome of AVF benefits more from acknowledging individual vascular conditions rather than age of the patient.